The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
BIM deletion polymorphism to predict systemic treatment outcome in advanced non-small cell lung cancer.
Jih-hsiang Lee
No relevant relationships to disclose
Yu-lin Lin
No relevant relationships to disclose
Hsuan-Yu Chen
No relevant relationships to disclose
Yeun-Chung Chang
No relevant relationships to disclose
Chong-Jen Yu
No relevant relationships to disclose
Jin-Yuan Shih
No relevant relationships to disclose
Kuan-Yu Chen
No relevant relationships to disclose
Pan-Chyr Yang
No relevant relationships to disclose
Chih-Hsin Yang
No relevant relationships to disclose